Bicara Therapeutics Inc (BCAX)
Operating Cash Flow (Statement)
-$44.21M
Quarterly · Period ending: · USD
BCAX Operating Cash Flow (Statement)
Latest reported-$44.21Mperiod ending
Latest reported-$44.21Mperiod ending
BCAX Quarterly Cash from Operations (-$13.53M → -$44.21M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
BCAX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -44,206,000 | |
| -37,508,000 | |
| -23,886,000 | |
| -29,248,000 | |
| -25,594,000 | |
| -28,106,000 | |
| -30,032,000 | |
| -17,224,000 | |
| -12,908,000 | |
| -14,587,000 | |
| -8,036,000 | |
| -10,532,000 | |
| -13,530,000 | |
| -13,530,000 |